{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:17:20Z","timestamp":1758403040301,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,18]]},"DOI":"10.1093\/eurjpc\/zwac110","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T15:37:24Z","timestamp":1655393844000},"page":"e314-e318","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of ideal cardiovascular health and its correlates in patients with inflammatory bowel disease, psoriasis and spondyloarthropathy"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-8766","authenticated-orcid":false,"given":"Jasmijn A M","family":"Sleutjes","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center , Dr. Molewaterplein 40, Room Na-6, PO Box 2040, 3015GD Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-9962","authenticated-orcid":false,"given":"Jeanine E","family":"Roeters van Lennep","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus Medical Center , Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepijn J P","family":"Verploegh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center , Dr. Molewaterplein 40, Room Na-6, PO Box 2040, 3015GD Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn B A","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus Medical Center , Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijn","family":"Vis","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Erasmus Medical Center , Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Cardiometabolic Disorders, Erasmus Medical Center , Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center , Dr. Molewaterplein 40, Room Na-6, PO Box 2040, 3015GD Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie C","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus Medical Center , Dr. Molewaterplein 40, Room Na-6, PO Box 2040, 3015GD Rotterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"2022101818165685300_zwac110-B1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/heartjnl-2019-316378","article-title":"Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice","volume":"108","author":"Agca","year":"2022","journal-title":"Heart"},{"key":"2022101818165685300_zwac110-B2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"2022101818165685300_zwac110-B3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamacardio.2020.0109","article-title":"Association of the duration of ideal cardiovascular health through adulthood with cardiometabolic outcomes and mortality in the Framingham offspring study","volume":"5","author":"Corlin","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022101818165685300_zwac110-B4","doi-asserted-by":"crossref","first-page":"100922","DOI":"10.1016\/j.pmedr.2019.100922","article-title":"Ideal cardiovascular health and quality of life among Finnish municipal employees","volume":"15","author":"Bergman","year":"2019","journal-title":"Prev Med Rep"},{"key":"2022101818165685300_zwac110-B5","doi-asserted-by":"crossref","first-page":"16353","DOI":"10.1038\/s41598-018-34746-4","article-title":"Relationship between cardiovascular health metrics and physical performance in community-living people: results from the Longevity check-up (Lookup) 7 + project","volume":"8","author":"Landi","year":"2018","journal-title":"Sci Rep"},{"key":"2022101818165685300_zwac110-B6","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022101818165685300_zwac110-B7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"author":"Bommel\u00e9","key":"2022101818165685300_zwac110-B8"},{"key":"2022101818165685300_zwac110-B9","doi-asserted-by":"crossref","first-page":"e8769","DOI":"10.1097\/MD.0000000000008769","article-title":"Underweight: another risk factor for cardiovascular disease?: a cross-sectional 2013 Behavioral Risk Factor Surveillance System (BRFSS) study of 491,773 individuals in the USA","volume":"96","author":"Park","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2022101818165685300_zwac110-B10","doi-asserted-by":"crossref","first-page":"e0195123","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS One"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwac110\/44144602\/zwac110.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/13\/e314\/46562701\/zwac110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/13\/e314\/46562701\/zwac110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T18:17:47Z","timestamp":1666117067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/29\/13\/e314\/6609261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":10,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,6,16]]},"published-print":{"date-parts":[[2022,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwac110","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"type":"print","value":"2047-4873"},{"type":"electronic","value":"2047-4881"}],"subject":[],"published-other":{"date-parts":[[2022,9,13]]},"published":{"date-parts":[[2022,6,16]]}}}